Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [2512]

Cabazitaxel is now available in the UK for the treatment of men with advanced prostate cancer resistant to other therapy

Cabazitaxel is now available in the UK for the treatment of men with advanced prostate cancer resistant to other...

Blocking key cell component could make 'smart drugs' effective for many cancer patients

Blocking key cell component could make 'smart drugs' effective for many cancer patients

Some oestrogen-negative breast cancer patients may benefit from prostate cancer therapy

Some oestrogen-negative breast cancer patients may benefit from prostate cancer therapy

New approach to cancer vaccines successful in early studies

New approach to cancer vaccines successful in early studies

Worse cancer outcomes in deprived UK areas highlighted

Worse cancer outcomes in deprived UK areas highlighted

Just under half of deaths in men with prostate cancer due to the disease

Just under half of deaths in men with prostate cancer due to the disease

ASCO 2011: Circulating tumour cells as surrogate for survival in prostate cancer

ASCO 2011: Circulating tumour cells as surrogate for survival in prostate cancer

IMRT cuts GI side effects from prostate cancer in half compared to 3D-CRT

IMRT cuts GI side effects from prostate cancer in half compared to 3D-CRT

Cancer in the developing world: a disaster waiting to happen

Cancer in the developing world: a disaster waiting to happen

Brisk walking may help men with prostate cancer

Brisk walking may help men with prostate cancer

More from ecancer